ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Myotonia | 17.05.02.013; 15.05.04.013 | - | - | Not Available |
Blood disorder | 01.05.01.004 | - | - | Not Available |
Respiratory syncytial virus infection | 22.07.02.002; 11.05.13.001 | 0.001519% | | Not Available |
Disease recurrence | 08.01.03.050 | 0.000760% | | Not Available |
Drug intolerance | 08.06.01.013 | 0.001899% | | Not Available |
Psychotic disorder | 19.03.01.002 | 0.001013% | | |
Pulmonary toxicity | 22.01.02.007; 12.03.01.013 | 0.000760% | | Not Available |
Urine analysis abnormal | 13.13.02.008 | 0.000253% | | Not Available |
Respiratory tract infection | 22.07.07.001; 11.01.08.017 | 0.000380% | | Not Available |
Unevaluable event | 08.01.03.051 | - | - | Not Available |
Poor quality sleep | 19.02.05.005; 17.15.04.002 | 0.000886% | | Not Available |
Increased bronchial secretion | 22.02.04.007 | 0.000253% | | Not Available |
Arterial insufficiency | 24.04.02.005 | - | - | Not Available |
Peripheral arterial occlusive disease | 24.04.03.010 | - | - | Not Available |
Hypophagia | 19.09.01.004; 14.03.01.006; 07.01.06.010 | 0.000886% | | Not Available |
Dark circles under eyes | 06.08.03.019; 08.01.03.054 | 0.000253% | | Not Available |
Chronic kidney disease | 20.01.03.017 | - | - | |
Neuropsychological test abnormal | 13.07.06.001 | - | - | Not Available |
Treatment failure | 08.06.01.017 | 0.000495% | | Not Available |
Liver injury | 12.01.02.003; 09.01.07.022 | 0.000380% | | Not Available |
Regurgitation | 07.01.07.004 | 0.000253% | | Not Available |
Oropharyngeal discomfort | 07.05.05.008; 22.02.05.027 | - | - | Not Available |
Oropharyngeal pain | 22.02.05.022; 07.05.05.004 | 0.001139% | | |
Mechanical urticaria | 10.01.06.004; 23.04.02.004 | 0.000253% | | Not Available |
Acute kidney injury | 20.01.03.016 | - | - | |
Hypoxic-ischaemic encephalopathy | 24.04.06.021; 22.02.02.011; 17.13.02.006 | 0.000066% | | Not Available |
Foetal growth restriction | 18.03.01.002 | 0.000886% | | |
Substance-induced psychotic disorder | 19.03.01.007; 12.03.01.053 | 0.000886% | | Not Available |
Hepatocellular carcinoma | 16.07.02.005; 09.04.02.010 | - | - | Not Available |
Drug reaction with eosinophilia and systemic symptoms | 23.03.05.005; 10.01.01.021 | - | - | Not Available |